News

Joel Wayment discusses the implications of the growing cell and gene therapy market on pharma supply chains.

Nico Vandaele shares how advanced modeling and simulations can be used to get ahead of future supply chain disruptions.

Raquel Vazquez discusses how data can be incorporated to make key decisions within the cold chain.

Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain transformation.

Rahul Shah and Mack MacKenzie explain how to unlock the ROI that rules-based systems have left on the table.

Shawn McGee discusses today's key risks in the pharma supply chain, and how to prevent disruptions.

In this week’s Pharma Pulse, GEODIS’ cold chain expansion in the Midwest, a potential multi-billion dollar shift in cell therapy, and the White House’s new push for psychedelic mental health treatments.

The facility opening coincides with rapid growth projections for the pharmaceutical cold chain industry in the coming years.

Identiv's ID-Safe portfolio expands NFC authentication and tamper detection to secure pharmaceutical supply chains against counterfeiting and fraud.

Ahead of LogiPharma Europe 2026, Richard Harrop explains why packaging must be more patient-centric.

Pharma importers can apply for tariff reimbursements through the US Customs and Border Protection’s online portal.

Lilly’s $7B deal for Kelonia aims to turn complex cell therapy into a simple injection, bypassing the slow, costly lab work of current cancer treatments.

President Trump signed an executive order to fast-track FDA review of psychedelic therapies for mental health conditions.

Anthony “TJ” Rizzo shares his outlook on the future of pharma cold chain technology.

Fran Gregory, VP of Emerging Therapies at Cardinal Health, discusses key findings from the company's 2026 Advanced Therapy Report.

Charley Maxwell explains why Annex 21 is not just a regulatory hurdle, but a key commercial risk point.

Roel van den Akker examines how the industry might evolve its trade, distribution, and payer strategies to scale GLP-1s for mass demand.

Anthony “TJ” Rizzo explains what makes an effective supply chain partnership, and how tech can be deployed alongside human experience.

In today’s Pharma Pulse, Walgreens reshapes pharmacist roles, pharmacies expand injectable access, GoodRx and Eli Lilly broaden GLP-1 access, radiopharma investment grows, and AbbVie signs a $745 million Haisco licensing deal.

Richard Harrop shares how pharma can strike a balance between performance, sustainability, and resilience in packaging design.

Seamus Keane discusses resilient supply chain design ahead of his panel at LogiPharma 2026.

Ahead of his presentation at LogiPharma 2026, Anthony “TJ” Rizzo discusses how automation and real-time monitoring can be deployed in supply chains.

Roel van den Akker evaluates how blockbuster GLP-1s may shift broader commercialization trends.

In a Q&A, Traci Miller discusses the evolving role of hub services as well as their commercial value.

Jessica Ledesma explores how hospital pharmacies are adopting autonomous cold storage to protect high-value medications.

Laura Blair explains why streamlining the patient journey via and simpler tools help ensure adherence from the point of prescription.

Mastering the PSMF is critical for inspection readiness, as it provides regulators an early look at your pharmacovigilance system's compliance.